Business Description
Arvinas is a New Haven-based biotechnology company focused on developing drugs that eliminate harmful proteins linked to serious diseases. Rather than blocking these proteins, its treatments are designed to remove them from the body entirely using a mechanism the body already employs naturally. The company has several experimental drugs in development targeting conditions such as prostate cancer, breast cancer, certain blood cancers, pancreatic cancer, and Parkinson's disease. Arvinas works alongside major pharmaceutical partners including Pfizer, Roche, and Bayer to advance its research pipeline.
